Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemiaAmir T. Fathi(Massachusetts General Hospital), Yi‐Bin Chen(Massachusetts General Hospital)HaematologicaDecember 29, 201610.3324/haematol.2016.158394Cited by 43SaveCiteExport RISWatch citationsRelated PapersAlisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial|The Lancet Haematology|2019|30